Q1 2022 Xvivo Perfusion AB Earnings Call Transcript
Ladies and gentlemen, welcome to the XVIVO Group Interim Report Q1 2022. I will now hand over to Dag Andersson, CEO. Sir, please go ahead.
()-&
Thank you very much, and good morning, good afternoon or good evening, depending on where in the world you are. So Kristoffer Nordstrom, CFO; and myself, we are very happy to be here in Gothenburg and present the Q1 report to you all. So let's start, let's kick off by talking a little bit about Q1 highlights, and there are quite a few highlights actually to note.
If we look at organic growth, we achieved a great organic growth in the quarter, 32%, and we also delivered an adjusted EBITDA margin of 17%. Worth noting as well, and this was actually already communicated in the last call. During last quarter of 2021 and in connection with the acquisition of STAR Teams, we established the third business area of services. So we have the 3 business areas: Thoracic, Abdominal and now also then Services.
If
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
